EUVIMEDEUVIMED entdecken
Crossref

Variational autoencoder-based deep learning and radiomics for predicting pathologic complete response to neoadjuvant chemoimmunotherapy in locally advanced oesophageal squamous cell carcinoma

Qing Gu iD, Shenlun Chen, Andre Dekker iD, Leonard Wee iD, Petros Kalendralis, Meng Yan, Jin Wang, Jingping Yuan, Youhua Jiang

British Journal of Radiology · 01.01.2026 · 99 (1177) · 133-142

DOI: 10.1093/bjr/tqaf239 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Radiology, online erschienen am 25.09.2025. Verfasst von Qing Gu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310…. Hauptthemen laut MEDLINE: Deep Learning, Neoadjuvant Therapy, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Medical Science and Technology Project of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Neoadjuvant chemoimmunotherapy (nCIT) is gradually becoming an important treatment strategy for patients with locally advanced oesophageal squamous cell carcinoma (LA-OSCC). This study aimed to predict the pathological complete response (pCR) of these patients using variational autoencoder (VAE)-based deep learning and radiomics technology.

Methods

A total of 253 LA-ESCC patients who were treated with nCIT and underwent enhanced CT at our hospital between July 2019 and July 2023 were included in the training cohort. VAE-based deep learning and radiomics were utilized to construct deep learning (DL) models and deep learning radiomics (DLR) models. The models were trained and validated via fivefold cross-validation among 253 patients. Forty patients were recruited from our institution between August 2023 and August 2024 as the test cohort.

Results

The AUCs of the DL and DLR models were 0.935 (95% CI: 0.786-0.992) and 0.949 (95% CI: 0.910-0.986) in the validation cohort and 0.839 (95% CI: 0.726-0.853) and 0.926 (95% CI: 0.886-0.934) in the test cohort. The performance gap between Precision and Recall of the DLR model was smaller than that of the DL model. The F1 scores of the DL and DLR models were 0.726 (95% confidence interval [CI]: 0.476-0.842) and 0.766 (95% CI: 0.625-0.842) in the validation cohort and 0.727 (95% CI: 0.645-0.811) and 0.836 (95% CI: 0.820-0.850) in the test cohort.

Conclusions

We constructed a DLR model to predict pCR in nCIT-treated LA-ESCC patients, which demonstrated superior performance compared to the DL model. Advances in knowledge We innovatively used VAE-based deep learning and radiomics to construct the DLR model for predicting pCR of LA-ESCC after nCIT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Deep LearningNeoadjuvant TherapyEsophageal Squamous Cell CarcinomaEsophageal NeoplasmsTomography, X-Ray ComputedImmunotherapyHumansMaleFemaleMiddle AgedAgedTreatment OutcomeRetrospective StudiesPathologic Complete ResponseAutoencoderRadiomics

Stichwörter der Autor:innen

deep learningneoadjuvant chemoimmunotherapyoesophageal squamous cell carcinomaradiomicsvariational autoencoder

Autor:innen und Institutionen

  • Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China.
  • Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
  • Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht 6229 ET, The Netherlands.
  • Department of Radiation Oncology, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center…
  • Department of Pathology, Renmin Hospital of Wuhan University, Wuchang District, Wuhan, Hubei 430060, China.
  • Department of Esophageal Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China.

ORCID-Profile: Qing Gu, Andre Dekker, Leonard Wee

Förderung

  • Medical Science and Technology Project of Zhejiang Province

Zitieren

APA

Gu, Q., Chen, S., Dekker, A., Wee, L., Kalendralis, P., Yan, M., Wang, J., Yuan, J., & Jiang, Y. (2026). Variational autoencoder-based deep learning and radiomics for predicting pathologic complete response to neoadjuvant chemoimmunotherapy in locally advanced oesophageal squamous cell carcinoma. British Journal of Radiology, 99(1177), 133-142. https://doi.org/10.1093/bjr/tqaf239

Vancouver

Gu Q, Chen S, Dekker A, Wee L, Kalendralis P, Yan M, et al. Variational autoencoder-based deep learning and radiomics for predicting pathologic complete response to neoadjuvant chemoimmunotherapy in locally advanced oesophageal squamous cell carcinoma. British Journal of Radiology. 2026;99(1177):133-142. doi:10.1093/bjr/tqaf239

BibTeX
@article{Gu2026,
  author = {Gu, Qing and Chen, Shenlun and Dekker, Andre and Wee, Leonard and Kalendralis, Petros and Yan, Meng and Wang, Jin and Yuan, Jingping and Jiang, Youhua},
  title = {Variational autoencoder-based deep learning and radiomics for predicting pathologic complete response to neoadjuvant chemoimmunotherapy in locally advanced oesophageal squamous cell carcinoma},
  journal = {British Journal of Radiology},
  year = {2026},
  volume = {99},
  number = {1177},
  pages = {133--142},
  doi = {10.1093/bjr/tqaf239}
}
Kostenlos starten →